Table 2 Baseline characteristics at the time of ECLS implantation*
N° | ECM (min) | GCS | HR | AP (mmHg) | Vasopressor | ECG | LVEF | Lactate (mmol/L) | Bicarbonate (mmol/L) |
|---|---|---|---|---|---|---|---|---|---|
1 § | 160 | 3 | 0 | 0 | Epinephrine | Asystole | Akinesia | - | 21.1 |
2 §¶ | 150 | 3 | 0 | 0 | Epinephrine | Asystole | - | > 30 | 17.8 |
3 §¶ | 170 | 3 | 0 | 0 | Epinephrine Isoproterenol | Asystole | Akinesia | 10.8 | 19 |
4 | 60 | 3 | 40 | 60/40 | Epinephrine | Bradycardia (QRS 183 ms) | Hypokinesia (LEVF 15%) | 5.85 | 29.6 |
5 | 70 | 3 | 0 | 0 | Epinephrine | Asystole | - | 7.3 | 26.3 |
6 | 50 | 3 | 0 | 0 | - | Asystole | Akinesia | - | - |
7 | 60 | 3 | 30 | 50/33 | Epinephrine Dobutamine | Bradycardia (QRS 214 ms) | Akinesia | - | 17.5 |
8 ¶ | No | 3 | 60 | 50/30 | Epinephrine Isoproterenol | Sinusal | - | 10.5 | 17.7 |
9 | No | 3 | 40 | 85/54 | Epinephrine Isoproterenol Dobutamine | Bradycardia (QRS 175 ms) | Hypokinesia | 9.65 | 19.6 |
10 ¶ | No | 3 | 68 | 71/52 | Epinephrine Dobutamine | Sinusal | Hypokinesia (LVEF 20%) | 0.57 | 17.2 |
11 | No | 3 | 60/48 | Epinephrine Dobutamine | Sinusal | Hypokinesia (LVEF 20%) | - | - | |
12 | No | 8 | 30 | 70/40 | Norepinephrine Isoproterenol Dopamine | Atrio-ventricular block | Hypokinesia (LVEF 25%) | 4.6 | 17.9 |
13** | No | 3 | 55 | 75/50 | Epinephrine | Sinusal | Hypokinesia (LVEF 30%) | 5.9 | 11.7 |
14 §¶ | No | 3 | 140 | 85/58 | Epinephrine | Ventricular tachycardia | Hypokinesia (LVEF 20%) | 8,8 | 20.2 |
15** ¶ | No | 3 | 85 | 82/56 | Epinephrine Norepinephrine | Right bundle-branch block | Hypokinesia (LVEF 25%) | 1.7 | 18 |
16 | No | 15 | 60 | 70/60 | Epinephrine | Bradycardia (QRS 203 ms) | Hypokinesia (LVEF 10%) | 3.7 | 22.4 |
17 | No | 15 | 36 | 60/40 | Epinephrine Dobutamine | Sinusal | Hypokinesia (LVEF 10%) | 3.7 | 19.9 |